KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Depreciation and Depletion (2023 - 2025)

Teladoc Health's Depreciation and Depletion history spans 3 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 6.04% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $13.3 million, up 30.75%, while the annual FY2025 figure was $13.3 million, 30.75% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $2.8 million at Teladoc Health, up from $2.6 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $4.3 million in Q2 2025 and bottomed at $1.7 million in Q2 2024.
  • The 3-year median for Depreciation and Depletion is $2.8 million (2024), against an average of $2.9 million.
  • The largest annual shift saw Depreciation and Depletion plummeted 42.35% in 2024 before it surged 154.73% in 2025.
  • A 3-year view of Depreciation and Depletion shows it stood at $2.8 million in 2023, then rose by 6.7% to $3.0 million in 2024, then decreased by 6.04% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Depreciation and Depletion are $2.8 million (Q4 2025), $2.6 million (Q3 2025), and $4.3 million (Q2 2025).